Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.
5/5 보강
TL;DR
The purpose of the guideline is to provide dermatologists with an evidence‐based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia.
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: androgenetic alopecia
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Based on a systematic literature research the efficacy of the currently available therapeutic options was assessed and therapeutic recommendations were passed in a consensus conference. The purpose of the guideline is to provide dermatologists with an evidence-based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia.
📑 코퍼스 인용 관계
· 인용됨 87
📑 인용한 논문 (6) ▾
- Sustainability of functional hair follicle activity: Impact of spatially anchored multifun… Bioactive materials · 2026
- Exploration of integrated targeted serum and hair metabolomic profiles in men with androge… Singapore medical journal · 2025
- A Scoping Review of Exosome Delivery Applications in Hair Loss. Cureus · 2025
- Exploring the Efficacy and Potential Mechanisms of Topical (L.) Extract in Treating Andro… Biology · 2025
- Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extr… Pharmaceutics · 2025
- Artificial Intelligence in Patient Education for Androgenetic Alopecia: A Comparative Stud… Dermatology practical & conceptual · 2025
연도별 인용 (2017–2026) · 합계 318
OpenAlex 토픽 ·
Hair Growth and Disorders
Nail Diseases and Treatments
Dermatology and Skin Diseases
🇰🇷 한글 요약 🌐 Abstract
【연구 목적】
유럽피부과포럼(European Dermatology Forum, EDF)이 남녀 안드로겐성 탈모(androgenetic alopecia, AGA)의 치료에 대한 근거중심(S3) 진료지침을 마련하여, 피부과 의사가 효과적이고 안전한 치료법을 선택할 수 있는 도구를 제공하는 것을 목표로 하였습니다.
【방법】
체계적 문헌고찰을 통해 현재 사용 가능한 AGA 치료 옵션의 유효성을 평가하였고, 합의 회의(consensus conference)를 거쳐 치료 권고안을 도출하였습니다.
【주요 결과】
AGA는 가장 흔한 탈모 질환으로 백인 남성의 최대 80%, 여성의 42%까지 영향을 미치며, 환자의 삶의 질(quality of life)을 현저히 저하시킵니다. 본 S3 지침은 남녀 AGA 환자에 대한 근거중심 치료 권고안을 제시합니다.
【임상적 시사점 (성형외과 의사 관점)】
모발이식(hair transplantation) 상담 시 수술 단독이 아닌, 미녹시딜(minoxidil)·피나스테리드(finasteride) 등 근거 기반 약물치료를 병행한 통합 치료 계획을 수립하는 것이 권고되며, 특히 여성 환자에서는 성별에 따라 치료 옵션과 안전성 프로파일이 다르므로 S3 지침에 따른 맞춤 접근이 필요합니다. 또한 진행성 질환임을 환자에게 충분히 설명하여 이식 후 비이식부의 추가 탈모에 대비한 장기적 약물 유지요법을 안내해야 합니다.
Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair loss with a pattern distribution. Moreover, its frequency increases with age and affects up to 80% Caucasian men and 42% of women. Patients afflicted with androgenetic alopecia may undergo significant impairment of quality of life. The European Dermatology Forum (EDF) initiated a project to develop evidence-based guidelines for the treatment of androgenetic alopecia. Based on a systematic literature research the efficacy of the currently available therapeutic options was assessed and therapeutic recommendations were passed in a consensus conference. The purpose of the guideline is to provide dermatologists with an evidence-based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia.
【연구 목적】 유럽피부과포럼(European Dermatology Forum, EDF)이 남녀 안드로겐성 탈모(androgenetic alopecia, AGA)의 치료에 대한 근거중심(S3) 진료지침을 마련하여, 피부과 의사가 효과적이고 안전한 치료법을 선택할 수 있는 도구를 제공하는 것을 목표로 하였습니다.
APA 7
Kanti, V., Messenger, A., Dobos, G., Reygagne, P., Finner, A., Blumeyer, A., Trakatelli, M., Tosti, A., V, D. M., Piraccini, B. M., Nast, A., & Blume-Peytavi, U. (2018). Evidence-based (s3) guideline for the treatment of androgenetic alopecia in women and in men - short version.. Journal of the European Academy of Dermatology and Venereology : JEADV, 32(1), 11-22. https://doi.org/10.1111/jdv.14624
Vancouver
Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. Jour. Euro. Acad. Derm. Vene. : JEAD.. 2018;32(1):11-22. doi:10.1111/jdv.14624
AMA 11
Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version. Jour. Euro. Acad. Derm. Vene. : JEAD.. 2018;32(1):11-22. doi:10.1111/jdv.14624
Chicago
Kanti, V., Messenger, A., Dobos, G., Reygagne, P., Finner, A., Blumeyer, A., Trakatelli, M., Tosti, A., V, D. M., Piraccini, B. M., and .... 2018. "Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version." Journal of the European Academy of Dermatology and Venereology : JEADV 32 (1): 11-22. https://doi.org/10.1111/jdv.14624
MLA 9
Kanti, V., et al. "Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version." Journal of the European Academy of Dermatology and Venereology : JEADV, vol. 32, no. 1, 2018, pp. 11-22. doi:10.1111/jdv.14624.
PMID
29178529 ↗
추출된 의학 개체 (NER)
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 질환 | androgenetic alopecia
|
안드로겐성 탈모 | dict | 6 | |
| 질환 | androgenetic alopecia
|
안드로겐성 탈모 | dict | 6 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
인용 관계
그래프 OA 노드: 8/8 (100%)
· 참조 0편 · 후속 8편
이 논문을 인용한 후속 연구 20
- Dermal exosomes containing miR-218-5p promote hair regeneration by regulating β-catenin signaling.
- Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase II…
- Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature.
- Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment o…
- Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs.
- Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination wit…
- Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systemat…
- Clinical and preclinical approach in AGA treatment: a review of current and new therapies in the reg…
- Effectiveness and Safety of Botulinum Toxin Type A in the Treatment of Androgenetic Alopecia.
- Protective Role of Nutritional Plants Containing Flavonoids in Hair Follicle Disruption: A Review.
- Status of research on the development and regeneration of hair follicles.
- Hair Growth-Promoting Effect of Resveratrol in Mice, Human Hair Follicles and Dermal Papilla Cells.
- Oral minoxidil use in androgenetic alopecia and telogen effluvium.
- Safety and efficacy of ALRV5XR in women with androgenetic alopecia or telogen effluvium: A randomise…
- Expert consensus on the management of Androgenetic Alopecia in India.
- Female Pattern Hair Loss: An Overview with Focus on the Genetics.
- Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and co…
- The efficacy of topical prostaglandin analogs for hair loss: A systematic review and meta-analysis.
- Psychology's medicalization of male baldness.
- Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Mi…
같은 제1저자의 인용 많은 논문 (4)
- Cicatricial alopecia.
- Frontal fibrosing alopecia: demographic and clinical characteristics of 490 cases.
- Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: a 104-week open-label clinical trial.
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- 피나스테리드가 전립선암 발생에 미치는 영향.
- COVID-19의 50가지 이상의 장기 후유증: 체계적 문헌고찰 및 메타분석.
- 양성 전립선 비대증의 임상적 진행에 대한 doxazosin, finasteride 및 병용 요법의 장기 효과.
- 양성 전립선 비대증 환자에서 finasteride의 효과. The Finasteride Study Group.
- 양성 전립선 비대증 남성에서 급성 요폐의 위험과 수술적 치료 필요성에 대한 finasteride의 효과. Finasteride Long-Term Efficacy and Safety Study Group.
- 원형 탈모.
📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능
-
Epidemiology and burden of alopecia areata: a systematic review.
TL;DRAA is the most prevalent autoimmune disorder and the second most prevalent hair loss disorder after androgenetic alopecia, and the lifetime risk in the global population is approxi…
-
Androgenetic alopecia: a review.
TL;DRA systematic review of the literature and candidate gene and genome-wide association studies have reported that single-nucleotide polymorphisms at different genomic loci are associ…
-
Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
TL;DRAlthough a variety of medical, surgical, light‐based and nutraceutical treatment options are available to slow or reverse the progression of AGA, it can be challenging to select ap…
-
Minoxidil and its use in hair disorders: a review.
TL;DRThis article aims to review and update current information on the pharmacology, mechanism of action, clinical efficacy, and adverse events of topical minoxidil.
-
Androgenetic Alopecia: Therapy Update.
TL;DRThis comprehensive review discusses the evaluation of AGA and the mechanisms of action, costs, efficacies, and safety profiles of existing, alternative, and upcoming therapeutics f…